| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Tiziana Life Sciences PLC (NASDAQ: TLSA)
TLSA Technical Analysis
3
| As on 9th Jun 2023 TLSA STOCK Price closed @ 0.74 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.82 & Sell for SHORT-TERM with Stoploss of 0.84 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TLSASTOCK Price
| Open | 0.76 | Change | Price | % |
| High | 0.80 | 1 Day | -0.02 | -2.63 |
| Low | 0.74 | 1 Week | 0.01 | 1.37 |
| Close | 0.74 | 1 Month | -0.13 | -14.94 |
| Volume | 56096 | 1 Year | -0.20 | -21.28 |
| 52 Week High 1.29 | 52 Week Low 0.51 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| TLSA Daily Charts |
TLSA Intraday Charts |
Whats New @ Bazaartrend |
TLSA Free Analysis |
|
|
TLSA Important Levels Intraday
| RESISTANCE | 0.86 |
| RESISTANCE | 0.82 |
| RESISTANCE | 0.80 |
| RESISTANCE | 0.77 |
| SUPPORT | 0.71 |
| SUPPORT | 0.68 |
| SUPPORT | 0.66 |
| SUPPORT | 0.62 |
TLSA Forecast May 2024
| 4th UP Forecast | 1.68 |
| 3rd UP Forecast | 1.38 |
| 2nd UP Forecast | 1.19 |
| 1st UP Forecast | 1.01 |
| 1st DOWN Forecast | 0.47 |
| 2nd DOWN Forecast | 0.29 |
| 3rd DOWN Forecast | 0.1 |
| 4th DOWN Forecast | -0.2 |
TLSA Weekly Forecast
| 4th UP Forecast | 0.97 |
| 3rd UP Forecast | 0.90 |
| 2nd UP Forecast | 0.85 |
| 1st UP Forecast | 0.81 |
| 1st DOWN Forecast | 0.67 |
| 2nd DOWN Forecast | 0.63 |
| 3rd DOWN Forecast | 0.58 |
| 4th DOWN Forecast | 0.51 |
TLSA Forecast2024
| 4th UP Forecast | 2.46 |
| 3rd UP Forecast | 1.91 |
| 2nd UP Forecast | 1.57 |
| 1st UP Forecast | 1.23 |
| 1st DOWN Forecast | 0.25 |
| 2nd DOWN Forecast | -0.09 |
| 3rd DOWN Forecast | -0.43 |
| 4th DOWN Forecast | -0.98 |
Tiziana Life Sciences PLC ( NASDAQ USA Symbol : TLSA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TLSA Business Profile
Tiziana Life Sciences plc, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology, inflammation, and infectious diseases. Its lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. The company is also developing Milciclib (TZLS-201), a small molecule inhibitor of various cyclin-dependent kinases, tropomycin receptor kinases, and Src family kinases controlling cell growth and malignant progression of cancer; and anti-Interleukin 6 receptor (IL6R) mAb (TZLS-501), a fully human monoclonal antibody for the treatment of IL6-induced inflammation, primarily to treat COVID-19 patients. It has a collaboration agreement with FHI Clinical to conduct a Phase 2 clinical trials for treating hospitalized severe COVID-19 patients with intranasal foralumab. The company was incorporated in 1998 and is based in London, the United Kingdom. Address: 107 Cheapside, London, United Kingdom, EC2V 6DN
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service